Invention Grant
- Patent Title: 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
-
Application No.: US16333079Application Date: 2017-09-06
-
Publication No.: US10927109B2Publication Date: 2021-02-23
- Inventor: Henrik Teller , Alexandros Vakalopoulos , Melissa Boultadakis Arapinis , Alexander Straub , Hanna Tinel , Markus Brechmann , Matthias Beat Wittwer , Maximilian Andreas Kullmann , Till Freudenberger , Thomas Mondritzki , Tobias Marquardt
- Applicant: Bayer Aktiengesellschaft , Bayer Pharma Aktiengesellschaft
- Applicant Address: DE Leverkusen; DE Berlin
- Assignee: Bayer Aktiengesellschaft,Bayer Pharma Aktiengesellschaft
- Current Assignee: Bayer Aktiengesellschaft,Bayer Pharma Aktiengesellschaft
- Current Assignee Address: DE Leverkusen; DE Berlin
- Agency: Morrison & Foerster LLP
- Priority: EP16188728 20160914,EP16202509 20161206
- International Application: PCT/EP2017/072339 WO 20170906
- International Announcement: WO2018/050510 WO 20180322
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/4375 ; A61P9/06 ; A61K31/551 ; A61K45/06 ; C07D491/107 ; C07D519/00 ; A61P9/00 ; A61P13/00
Abstract:
The present application relates to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prevention of diseases, and to their use for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders and/or renal disorders.
Public/Granted literature
- US20190263805A1 7-SUBSTITUTED 1-ARYL-NAPHTHYRIDINE-3-CARBOXYLIC ACID AMIDES AND USE THEREOF Public/Granted day:2019-08-29
Information query
